Stock NEOP NEOPROBE
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications NEOPROBE OTC Bulletin Board

Equities

NEOP

US6405181065

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for NEOPROBE
2023 Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding CI
2023 Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. NAVB Stock
  4. NEOP Stock
  5. News NEOPROBE
  6. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW